HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MSD KK

Division of Merck & Co. Inc.
www.msd.co.jp

Latest From MSD KK

Turkey’s Domestic Vaccine Production Drive Prompts New Partnerships

The Turkish government’s drive to establish domestic manufacturing for vaccines is showing tentative signs of getting off the ground. New partnerships are forming between Turkish and international partners. However, lack of local know-how is hampering progress.

 

Turkey Vaccines

ViiV’s Potential HIV Blockbuster Among Latest Drugs To Win EMA Nod

A total of 13 new drugs have been recommended for pan-EU approval, while one has failed to meet the European Medicines Agency’s standards.

Europe Approvals

Japan Keytruda NSCLC Approval Sets Stage For Opdivo Showdown

Keytruda has been approved in Japan for lung cancer, including first-line use, in a batch of new regulatory clearances that also include the country's first prescription drug for irritable bowel syndrome with constipation.

Japan Approvals

Ono Files Japan Patent Action As Keytruda Nears Market

Hot on the heels of Keytruda's US approval for first-line use in lung cancer, and just ahead of the drug’s first local launch, rival PD-1 player Ono has launched a patent infringement suit in Japan against Merck, adding to similar actions brought elsewhere by its global Opdivo partner BMS.

Legal Issues Japan
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Merck & Co. Inc.
  • Senior Management
  • Tony Alvarez, Pres.
  • Contact Info
  • MSD KK
    Phone: 03 6272 0088
    13th No. 12 Kitanomaru Sq.
    Kudankita chome
    Tokyo,
    Japan
UsernamePublicRestriction

Register